切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2009, Vol. 03 ›› Issue (06) : 659 -664. doi: 10.3877/cma.j.issn.1674-0807.2009.06.010

综述

Clusterin在乳腺癌研究中的进展
徐亮1, 张瑾1,()   
  1. 1.300060 天津,天津医科大学附属肿瘤医院乳腺三科
  • 收稿日期:2008-11-05 出版日期:2009-12-01
  • 通信作者: 张瑾

Progression of clusterin in the research of breast cancer

Liang XU, Jin ZHANG()   

  • Received:2008-11-05 Published:2009-12-01
  • Corresponding author: Jin ZHANG
引用本文:

徐亮, 张瑾. Clusterin在乳腺癌研究中的进展[J/OL]. 中华乳腺病杂志(电子版), 2009, 03(06): 659-664.

Liang XU, Jin ZHANG. Progression of clusterin in the research of breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2009, 03(06): 659-664.

[1]
Hasan Q,Rüger B M,Tan S T,et al.Clusterin/apoJ expression during the development of hemangioma.Hum Pathol,2000,31:691-697.
[2]
Gleave M E,Zellweger T,Chi K,et al.Targeting anti-apoptotic genes upregulated by androgen withdrawal using antisense oligonucleotides to enhance androgen-and chemo-sensitivity in prostate cancer.Invest New Drugs,2002,20:145-158.
[3]
Shannan B,Seifert M,Leskov K,et al.Challenge and promise:roles for clusterin in pathogenesis,progression and therapy of cancer.Cell Death Differ,2006,13:12-19.
[4]
Pajak B,Orzechowski A.Clusterin:the missing link in the calcium dependent resistence of cancer cells to apoptosis stimuli.Postepy Hig Med Dosw(Online),2006,60:45-51.
[5]
Jones S E,Jomary C.Clusterin.Int J Biochem Cell Biol,2002,34:427-431.
[6]
Charnay Y,Imhof A,Vallet P G,et al.Clusterin expression during fetal and postnatal CNS development in mouse.Neuroscience,2008,155:714-24.
[7]
Schwarz M,Spath L,Lux C A,et al.Potential protective role of apoprotein J(clusterin)in atherogenesis:Binding to enzymatically modified low-density lipoprotein reduces fatty acid-mediated cytotoxicity.Thromb Haemost,2008,100:110-118.
[8]
Yamada K,Hori Y,Hanafusa N,et al.Clusterin is up-regulated in glomerular mesangial cells in complement-mediated injury.Kidney Int,2001,59:137-146.
[9]
Gleave M,Miyake H.Use of antisense oligonucleotides targeting the cytoprotective gene.clusterin,to enhance androgen and chemo-sensitivity in prostate cencer.World J Urol,2005,23:38-46.
[10]
Cristwell T,Klokov D,Beman M,et al.Regression of IR—indecible clusterin expression by the p53 tumor suppressor protein.Cancer Biol Ther,2003,2:372-380.
[11]
Pucci S,Bonanno E,Pichiorri F,et al.Modulation of different clusterin isoforms in human colon tumorigenesis.Oncogene,2004,23:2298-2304.
[12]
Zhang H,Kim J K,Edwards C,et al.Clusterin inhibits apoptosis by interacting with activated Bax.Nat Cell Biol,2005,7:909-915.
[13]
Zhang S,Zhang D F,Jing M Y,et al.COX proportional hazards model analysis on breast cancer prognosis and the correlation with clusterin expression.Chin J Cancer Prev treat,2007,14:1314-1317.
[14]
Ammar H,Closset J L.Clusterin activities survival through the phosohatidylinositol 3-kinase/Akt pathway.J Bilo Chem,2008,283:12 851-12 861.
[15]
Narita S,So A,Ettinger S,et al.GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent peostate cancer.Clin Cancer Res,2008,14:5769-5777.
[16]
Sowery R D,Hadaschik B A,So A I,et al.Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sentitizes docetaxel-refractory prostate cencer PC-3 cells to chemithreapy.BJU Int,2008,102:389-397.
[17]
Gao Z C,Chen R,Zhou P,et al.Anti-apoptpsis effect of clusterin in lovo cells.Journal of Luzhou Medical College,2007,30:363-366.
[18]
Xie D,Sham J S,Zeng W F,et al.Oncogenetic role of clusterin overexpression in multistage colorectal tumorigenesis and progression.World J Gastroenterol,2005,11:3285-3289.
[19]
Sun B,Zhang S,Liu Y,et al.Clusterin is associated with spontaneous breast cancer in TA2 mice.FEBS Lett,2007,581:3277-3282.
[20]
Takase O,Minto A W,Puri T S,et al.Inhibition of NF-κB-dependent Bcl-xl expression by clusterin promotes albumininduced tubular cell apoptosis.Kidney International,2008,73:567-577.
[21]
Redondo M,Villar E,Torres Munoz J,et al.Overexpression of clusterin in human breast carcinoma.Am J Pathol,2000,157:393-399.
[22]
Krüger S,Ola V,Fischer D,et al.Prognostic significance of clusterin immunoreacetivity in breast cancer.Neoplasma,2007,54:46-50.
[23]
So A,Sinnemann S,Huntsman D,et al.Knockdown of the cytoprotective chaperone,clusterin,chemosensitizes human breast cancer cells both in vitro and in vivo.Mol Cancer Ther,2005,4:1837-1849.
[24]
Cappelletti V,Gariboldi M,De Cecco L,et al.Patterns and changes in gene expression following neo-adjuvant anti estrogen treatment in estrogen receptor-positive breast cancer.Endocr Realt Cancer,2008,15:439-449.
[25]
Sutton D,Kim S,Shuai X,et al.Efficient suppression of secretory clusterin levels by polymer-siRNA nanocomplexes enhances ionizing radiation letality in human MCF-7 breast cancer cells in vitro.Int J Nanomedicine,2006,1:155-162.
[26]
Biroccio A,D'Angelo C,Jansen B,et al.Antisense Clusterin Oligodeoxynucleotides Increase the response of HER-2 gene amplified breast cancer cells to trastuzumab.J Cell Physiol,2005,204:463-469.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[4] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[5] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[6] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[7] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[8] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[9] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[10] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[11] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[12] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[13] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[14] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[15] 王国强, 张纲, 唐建坡, 张玉国, 杨永江. LINC00839 调节miR-17-5p/WEE1 轴对结直肠癌细胞增殖、凋亡和迁移的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 491-499.
阅读次数
全文


摘要